News

Stanford's milli-spinner removes tough clots by shrinking them, not tearing them, with a 90 percent first-try success in stroke models.
While some practices lower the risk for complications with peripherally inserted central catheters, evidence gaps highlight ...
This prospective study was designed to compare the efficacy and safety of catheter removal on POD 2 versus POD 4 after LRP and its impact on urinary continence outcomes. In this study, 94.7 % of ...
Researchers explored the use of catheter salvage therapy for central line-associated bloodstream infection management in ...
Anaconda Biomed announced today that it received CE mark approval to commercialize its ANA5 funnel catheter in Europe.
Stanford researchers have developed a new mechanical thrombectomy device that could improve how doctors treat stroke and other clot-related diseases.
The Connecticut pastor went to the hospital in late November because he needed a medical device replaced. He died on ...
Anaconda Biomed, SL, announced that it has received CE Mark certification for its ANA5 advanced neurovascular access funnel ...
Researchers have developed a novel device that quite literally spins away the clots that block blood flow to the brain and ...